Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
- PMID: 34260770
- PMCID: PMC8447396
- DOI: 10.1111/jdv.17522
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
Conflict of interest statement
Dr Koch received grants from Novartis and honoraria as speaker and travel fees from Novartis, Bristol Myers Squibb, Roche and Merck & Co. Dr Mondaca has received consulting fees from Roche and Foundation Medicine and honoraria as speaker from Bristol Myers Squibb and Merck & Co.
Figures
Similar articles
-
Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort study.J Am Acad Dermatol. 2022 Nov;87(5):1217-1219. doi: 10.1016/j.jaad.2022.06.031. Epub 2022 Jun 20. J Am Acad Dermatol. 2022. PMID: 35738513 Free PMC article. No abstract available.
-
Impact of the COVID-19 pandemic on the diagnosis and management of primary cutaneous melanomas in New South Wales, Australia: A retrospective cohort study.Aust J Gen Pract. 2024 Dec-Supplement;53(12 Suppl):S71-S77. doi: 10.31128/AJGP-10-23-6991. Aust J Gen Pract. 2024. PMID: 39693756
-
Comment on "The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience".J Am Acad Dermatol. 2021 Dec;85(6):e419-e420. doi: 10.1016/j.jaad.2021.08.039. Epub 2021 Aug 28. J Am Acad Dermatol. 2021. PMID: 34464625 Free PMC article. No abstract available.
-
Challenges and lessons in establishing human immune profiling cohort studies for pandemic response.Immunol Rev. 2022 Aug;309(1):8-11. doi: 10.1111/imr.13110. Epub 2022 Jun 30. Immunol Rev. 2022. PMID: 35770708 Review.
-
Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.BMJ Glob Health. 2021 Nov;6(11):e007433. doi: 10.1136/bmjgh-2021-007433. BMJ Glob Health. 2021. PMID: 34740916 Free PMC article.
Cited by
-
The impact of the COVID-19 pandemic on the characteristics of melanoma: a single-centre cohort study.Postepy Dermatol Alergol. 2023 Oct;40(5):638-641. doi: 10.5114/ada.2023.132247. Epub 2023 Nov 9. Postepy Dermatol Alergol. 2023. PMID: 38028407 Free PMC article.
-
Heterogeneity of reports about the impact of the COVID-19 pandemic on melanoma diagnosis.Br J Dermatol. 2022 Aug;187(2):135-136. doi: 10.1111/bjd.21598. Epub 2022 May 24. Br J Dermatol. 2022. PMID: 35610054 Free PMC article.
-
Prolonged impact of COVID-19 pandemic on delayed melanoma diagnosis: further data based on one-year appraisal from Italy.Dermatol Reports. 2022 Jul 7;15(1):9535. doi: 10.4081/dr.2022.9535. eCollection 2023 Mar 7. Dermatol Reports. 2022. PMID: 37034472 Free PMC article. No abstract available.
-
The Epidemiology of Malignant Melanoma during the First Two Years of the COVID-19 Pandemic: A Systematic Review.Int J Environ Res Public Health. 2022 Dec 25;20(1):305. doi: 10.3390/ijerph20010305. Int J Environ Res Public Health. 2022. PMID: 36612627 Free PMC article.
-
The impact of the COVID-19 pandemic on melanoma diagnosis: a systematic review and meta-analysis of global evidence.BMC Public Health. 2025 Aug 6;25(1):2684. doi: 10.1186/s12889-025-23926-3. BMC Public Health. 2025. PMID: 40770795 Free PMC article.
References
-
- Breitbart EW, Waldmann A, Nolte S et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201–211. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical